Another pharmaceutical company has settled with the state, but the trial against the nation’s largest drug manufacturer is still set to get underway this week, Oklahoma Attorney General Mike Hunter announced on Sunday.
Teva Pharmaceuticals has agreed to an $85 million settlement with the state, according to a news release from the Attorney General’s Office. Specific terms of the settlement may take up to two weeks to finalize and will be released at a later date.
Money from the settlement will be used to address the opioid crisis in the state, Hunter said.
The attorney general said his office remains focused on the state’s trial against Johnson & Johnson, which is set to get underway Tuesday in Cleveland County District Court.
“Today’s announcement is a testament to the state’s legal team’s countless hours and resources preparing for this trial and their dedication and resolve to hold the defendants in this case accountable for the ongoing opioid overdose and addiction epidemic that continues to claim thousands of lives each year,” Hunter said in his news release. “Nearly all Oklahomans have been negatively impacted by this deadly crisis and we look forward to Tuesday, where we will prove our case against Johnson & Johnson and its subsidiaries.”
Israeli-based Teva is the second defendant to settle with the state. Purdue Pharma agreed to a $270 million settlement in March, with the majority of the money going to the Oklahoma State University Center for Wellness and Recovery. The university will use the money to fund addiction treatment and research.
The state’s newest settlement agreement resolves claims against Teva Pharmaceuticals USA Inc., Cephalon Inc., Watson Laboratories Inc., Actavis LLC., and Actavis Pharma Inc.